Development of coagulation factor probes for the identification of procoagulant circulating tumor cells

Frontiers in Oncology

Volumn 2 SEP, Issue , 2012, Pages

  Tormoen, Garth W ^a   Cianchetti, Flor A ^a   Bock, Paul E ^b   McCarty, Owen J T ^a,c,d  

^a Oregon Health and Science University Department of Biomedical Engineering   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Circulating tumor cell; Coagulation; Tissue factor

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7A; LIPOCORTIN 5; PROTHROMBIN A; RIVAROXABAN;

ARTICLE; BLOOD CLOTTING TIME; CIRCULATING TUMOR CELL; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; METASTASIS; PROCOAGULANT CIRCULATING TUMOR CELL; VEIN THROMBOSIS;

EID: 84878849027     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2012.00110     Document Type: Article

References (32)

1. Akl, E. A., Vasireddi, S. R., Gunukula, S., Yosuico, V. E., Barba, M., Terrenato, I., Sperati, F., and Schunemann, H. (2011). Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation. Cochrane Database Syst. Rev. CD006466.
2. Ashworth, T. R. (1869). A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aust. Med. J. 14, 146-147.
3. Baron, J. A., Gridley, G., Weiderpass, E., Nyren, O., and Linet, M. (1998). Venous thromboembolism and cancer. Lancet 351, 1077-1080.
4. Barrowcliffe, T. W., Fabregas, P., Jardi, M., Cancelas, J., Rabaneda, M., and Felez, J. (2002). Procoagulant activity of T lymphoblastoid cells due to exposure of negatively charged phospholipid. Thromb. Haemost. 87, 442-449.
5. Baugh, R. J., Broze, G. J. Jr., and Krishnaswamy, S. (1998). Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor. J. Biol. Chem. 273, 4378-4386.
6. Berny-Lang, M. A., Aslan, J. E., Tormoen, G. W., Patel, I. A., Bock, P. E., Gruber, A., and McCarty, O. J. (2011). Promotion of experimental thrombus formation by the procoagulant activity of breast cancer cells. Phys. Biol. 8, 015014.
7. Bock, P. E. (1992). Active-site-selective labeling of blood coagulation proteinases with fluorescence probes by the use of thioester peptide chloromethyl ketones. II. Properties of thrombin derivatives as reporters of prothrombin fragment 2 binding and specificity of the labeling approach for other proteinases. J. Biol. Chem. 267, 14974-14981.
8. Cohen, S. J., Punt, C. J., Iannotti, N., Saidman, B. H., Sabbath, K. D., Gabrail, N. Y., Picus, J., Morse, M., Mitchell, E., Miller, M. C., Doyle, G. V., Tissing, H., Terstappen, L. W., and Meropol, N. J. (2008). Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J. Clin. Oncol. 26, 3213-3221.
9. Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W., and Hayes, D. F. (2004). Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N. Engl. J. Med. 351, 781-791.
10. Danila, D. C., Heller, G., Gignac, G. A., Gonzalez-Espinoza, R., Anand, A., Tanaka, E., Lilja, H., Schwartz, L., Larson, S., Fleisher, M., and Scher, H. I. (2007). Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clin. Cancer Res. 13, 7053-7058.
11. de Bono, J. S., Scher, H. I., Montgomery, R. B., Parker, C., Miller, M. C., Tissing, H., Doyle, G. V., Terstappen, L. W., Pienta, K. J., and Raghavan, D. (2008). Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin. Cancer Res. 14, 6302-6309.
12. Falanga, A., and Marchetti, M. (2009). Venous thromboembolism in the hematologic malignancies. J. Clin. Oncol. 27, 4848-4857.
13. Gleghorn, J. P., Pratt, E. D., Denning, D., Liu, H., Bander, N. H., Tagawa, S. T., Nanus, D. M., Giannakakou, P. A., and Kirby, B. J. (2010). Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody. Lab. Chip 10, 27-29.
14. Itakura, A., Verbout, N. G., Phillips, K. G., Insall, R. H., Gailani, D., Tucker, E. I., Gruber, A., and McCarty, O. J. (2011). Activated factor XI inhibits chemotaxis of polymorphonuclear leukocytes. J. Leukoc. Biol. 90, 923-927.
15. Lu, G., Broze, G. J. Jr., and Krishnaswamy, S. (2004). Formation of factors IXa and Xa by the extrinsic pathway: differential regulation by tissue factor pathway inhibitor and antithrombin III. J. Biol. Chem. 279, 17241-17249.
16. Marrinucci, D., Bethel, K., Kolatkar, A., Luttgen, M. S., Malchiodi, M., Baehring, F., Voigt, K., Lazar, D., Nieva, J., Bazhenova, L., Ko, A. H., Korn, W. M., Schram, E., Coward, M., Yang, X., Metzner, T., Lamy, R., Honnatti, M., Yoshioka, C., Kunken, J., Petrova, Y., Sok, D., Nelson, D., and Kuhn, P. (2012). Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers. Phys. Biol. 9, 016003.
17. McCarty, O. J., Jadhav, S., Burdick, M. M., Bell, W. R., and Konstantopoulos, K. (2002). Fluid shear regulates the kinetics and molecular mechanisms of activation-dependent platelet binding to colon carcinoma cells. Biophys. J. 83, 836-848.
18. Morris, D. R., Ding, Y., Ricks, T. K., Gullapalli, A., Wolfe, B. L., and Trejo, J. (2006). Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells. Cancer Res. 66, 307-314.
19. Nagrath, S., Sequist, L. V., Maheswaran, S., Bell, D. W., Irimia, D., Ulkus, L., Smith, M. R., Kwak, E. L., Digumarthy, S., Muzikansky, A., Ryan, P., Balis, U. J., Tompkins, R. G., Haber, D. A., and Toner, M. (2007). Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450, 1235-1239.
20. Panizzi, P., Friedrich, R., Fuentes-Prior, P., Kroh, H. K., Briggs, J., Tans, G., Bode, W., and Bock, P. E. (2006). Novel fluorescent prothrombin analogs as probes of staphylocoagulase-prothrombin interactions. J. Biol. Chem. 281, 1169-1178.
21. Pickering, W., Gray, E., Goodall, A. H., Ran, S., Thorpe, P. E., and Barrowcliffe, T. W. (2004). Characterization of the cell-surface procoagulant activity of T-lymphoblastoid cell lines. J. Thromb. Haemost. 2, 459-467.
22. Rickles, F. R., and Levine, M. N. (2001). Epidemiology of thrombosis in cancer. Acta Haematol. 106, 6-12.
23. Sampson-Johannes, A., Wang, W., and Shtivelman, E. (1996). Colonization of human lung grafts in SCID-hu mice by human colon carcinoma cells. Int. J. Cancer 65, 864-869.
24. Sorensen, H. T., Mellemkjaer, L., Olsen, J. H., and Baron, J. A. (2000). Prognosis of cancers associated with venous thromboembolism. N. Engl. J. Med. 343, 1846-1850.
25. Tormoen, G. W., Rugonyi, S., Gruber, A., and McCarty, O. J. (2011). The role of carrier number on the procoagulant activity of tissue factor in blood and plasma. Phys. Biol. 8, 066005.
26. Trousseau, A. (1865). Phlegmasia Alba Dolens. Clinique Medicale de l'Hotel-Dieu de Paris. Paris: The Syndenham Society, 654-712.
27. Tucker, E. I., Marzec, U. M., White, T. C., Hurst, S., Rugonyi, S., McCarty, O. J., Gailani, D., Gruber, A., and Hanson, S. R. (2009). Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI. Blood 113, 936-944.
28. Welsh, J., Smith, J. D., Yates, K. R., Greenman, J., Maraveyas, A., and Madden, L. A. (2012). Tissue factor expression determines tumour cell coagulation kinetics. Int. J. Lab. Hematol. 34, 396-402.
29. White-Adams, T. C., Berny, M. A., Tucker, E. I., Gertz, J. M., Gailani, D., Urbanus, R. T., De Groot, P. G., Gruber, A., and McCarty, O. J. (2009). Identification of coagulation factor XI as a ligand for platelet apolipoprotein E receptor 2 (ApoER2). Arterioscler. Thromb. Vasc. Biol. 29, 1602-1607.
30. Yates, K. R., Welsh, J., Echrish, H. H., Greenman, J., Maraveyas, A., and Madden, L. A. (2011). Pancreatic cancer cell and microparticle procoagulant surface characterization: involvement of membrane-expressed tissue factor, phosphatidylserine and phosphatidylethanolamine. Blood Coagul. Fibrinolysis 22, 680-687.
31. Zhang, R. D., Fidler, I. J., and Price, J. E. (1991). Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis. Invasion Metastasis 11, 204-215.
32. Zhou, H., Hu, H., Shi, W., Ling, S., Wang, T., and Wang, H. (2008). The expression and the functional roles of tissue factor and protease-activated receptor-2 on SW620 cells. Oncol. Rep. 20, 1069-1076.